Birdshot Chorioretinopathy treated with dexamethasone intravitreal implant and a biologic response modifier: a successful management
DOI:
https://doi.org/10.20513/2447-6595.2017v57n3p54-57Palabras clave:
Uveitis. Birdshot chorioretinopathy. HLA-A29. Retinal vasculitis. Anti-inflammatory agents.Resumen
Birdshot chorioretinopathy is an organ-specific, potentially blinding chronic of bilateral inflammation of the posterior eye segment. It is seen mainly in persons who have the HLA-A29 haplotype. The diagnosis remains clinical and is based in his hallmark, which is the presence of multiples white dots throughout the fundus, resembling a shotgun pattern. The immune mechanisms involved in its pathogenesis remains unclear and the long-term outcome is guarded. However, the use of immunosuppressive agents and newer therapies demonstrated control of the inflammation and is a hope mainly in refractory cases. We report a case of Birdshot chorioretinopathy treated successfully with steroids and immunosuppressive agents.Descargas
Los datos de descargas todavía no están disponibles.
Descargas
Publicado
2017-12-04
Número
Sección
RELATOS DE CASO